Overview

Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate

Status:
Unknown status
Trial end date:
2020-02-19
Target enrollment:
Participant gender:
Summary
A randomized, prospective study comparing methylene blue versus terlipressin in treatment of catecholamines resistant shock in preterm neonate
Phase:
Phase 2
Details
Lead Sponsor:
Ain Shams University
Treatments:
Arginine Vasopressin
Methylene Blue
Terlipressin
Vasopressins